LOS ANGELES--(BUSINESS WIRE)--CompuMed, Inc. (OTCBB:CMPD) – a leading provider of imaging technology for skeletal health, and the company behind the OsteoGram™ system for bone density screening – today announced that the United States Patent and Trademark Office has issued the company a patent for an automated method and system to assess or monitor the extent or progression of joint-damaging diseases such as osteoarthritis and rheumatoid arthritis.
